Human Angiopoietin-2 ELISA

Catalog number: BI-ANG2
Brand: Biomedica
Packing: 96 tests
Price: € 710.00
Expected delivery time: 7 days
Quantity:

Product specifications for - Human Angiopoietin-2 ELISA

Overview: 
Product group: Assays
Category: ELISA / EIA
Application note: ELISA
Species: Human
Reactivity note: human
Properties: 
Molecular weight: 54.9 kDa
Assay Sensitivity: 3.7 pmol/l (= 203 pg/ml)
Assay Specificity: ANG2 (synonyms: ANGPT2, Angiopoietin 2, Angiopoietin-2, ANG-2, Angiopoietin-2B, Angiopoietin-2a, Tie2-Ligand)
Assay Precision: intra-assay: 6%, inter-assay: 8%
Assay Sample Type: Serum, EDTA plasma, heparin plasma, citrate plasma
Assay Time: 2 h / 1 h / 30 min
Assay Detection Range: 3.7 - 400 pmol/l
Datasheet: Datasheet
  Research Use Only
UNSPSC: 41116133
Scientific information: 
Scientific info: Product Characteristics: The Human Angiopoietin-2 immunoassay is a 3.5 h, 96-well sandwich ELISA for the quantitative determination of Angiopoietin-2 in serum and plasma.Target information: Angiopoietin-2 (ANG2) is a glycosylated growth factor that is specific for endothelial cells (ECs). ANG2 is expressed in embryonic vessels and contributes to the formation of new vasculature. In adults, it is restricted to sites of vascular remodeling (e.g. ovary, uterus, placenta) and wound healing. ANG2 is regulated by the cytokine vascular endothelial growth factor (VEGF). Together with VEGF, ANG2 induces endothelial cell migration, proliferation, and vascular sprouting. During angiogenesis, ANG2 exerts its effects via the angiopoietin-1/TIE2 receptor signaling system on endothelial cells. Disruption of this signaling leads to the loss of endothelial integrity. In consequence, the endothelium responds to various pro-inflammatory cytokines and growth factors. Thus, ANG2 might cause vascular micro-inflammation in patients with chronic kidney disease (CKD). Various studies demonstrated that ANG2 levels increase with CKD stage and are associated with fluid overload and abnormal cardiac structure. Furthermore, ANG2 concentrations correlate with mortality in patients with CKD stages 4-5. Although ANG2 levels recover after successful kidney transplantation, ANG2 continues to be a cardiovascular risk factor in this population. In cancer, targeting the TIE2-Angiopoietin pathway has shown promising results in some pre-clinical and clinical trials, including studies on recurrent or metastatic breast and renal cell carcinomas.
Gene ID: 284
Swiss prot ID: Q15389
Safety information: 
MSDS: MSDS
Additional information: 
Synonyms: BI-ANG2; Biomedica Gruppe
Chu C et al., “Angiopoietin-2 predicts all-cause mortality in male but not female end-stage kidney disease patients on hemodialysis.” Nephrol Dial Transplant. (2021) Nov 18:gfab332. doi: 10.1093/ndt/gfab332. Read more
Suciu A et al., New bioactive angiopoietin-2 ELISA allows the quantification of all three isoforms of angiopoietin-2 in chronic kidney disease.” ERA-EDTA (2019); SP 339. Read more
All Citations Read more